Commentary on a reanalysis of the 4-year results from the Evolut Low Risk trial, excluding Abbott/St. Jude Trifecta prostheses from the surgical cohort.
Subanalysis of the REGROUP trial assessing 5-year outcomes after surgical revascularization in patients with at least one totally occluded coronary vessel versus those without any occlusions.
A commentary on a review article exploring the current state of randomized evidence and its role in advancing cardiac surgery.
Subanalysis of the hemodynamic performance by echocardiography of Edwards LifeSciences® surgical bioprostheses and TAVR devices in the PARTNER 3 trial with five-year follow-up
Comparative outcomes of the CORONEO® external ring versus a homemade Dacron ring for annular stabilization in aortic root remodeling surgery.
A meta-analysis of 11 studies confirms the superiority of the GERAADA score over EuroSCORE II for predicting 30-day surgical risk in patients with acute aortic dissection.
Meta-analysis of the longest available follow-up outcomes from the six main randomized trials comparing TAVI and SAVR in low surgical risk patients in terms of survival and stroke.
Seventeen-year outcomes from the SWEDEHEART registry comparing morbidity and mortality after coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).
Analysis of the outcomes of the observational PRIORITY cohort, focusing on the 10-year results of patients undergoing coronary revascularization surgery and assessing the impact of diabetes mellitus.
Comparative study on the behavior of TAVI prostheses implanted in bicuspid and tricuspid aortic valves, focusing on deformation, development of paravalvular leakage, and thrombosis.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.